Statements (19)
| Predicate | Object |
|---|---|
| gptkbp:instanceOf |
gptkb:biotechnology
|
| gptkbp:foundedIn |
1886
|
| gptkbp:founder |
gptkb:Alfred_Kern
gptkb:Edouard_Sandoz |
| gptkbp:headquartersLocation |
gptkb:Basel,_Switzerland
|
| gptkbp:industry |
Pharmaceuticals
|
| gptkbp:notableEvent |
Known for production of LSD in the 20th century
Merged with Ciba-Geigy to form Novartis in 1996 Spun off as independent company in 2023 |
| gptkbp:notableProduct |
Generic drugs
Biosimilars |
| gptkbp:numberOfEmployees |
~22,000 (2022)
|
| gptkbp:parentCompany |
gptkb:Novartis
|
| gptkbp:stockExchange |
gptkb:SIX_Swiss_Exchange
|
| gptkbp:stockSymbol |
gptkb:SDZ
|
| gptkbp:website |
https://www.sandoz.com/
|
| gptkbp:bfsParent |
gptkb:Novartis_AG
|
| gptkbp:bfsLayer |
8
|
| https://www.w3.org/2000/01/rdf-schema#label |
Sandoz (until 2023)
|